Chemotherapy With Anlotinib in Advanced Cervical Cancer: A Prospective, Single-arm Study
Latest Information Update: 05 Jan 2023
Price :
$35 *
At a glance
- Drugs Catequentinib (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- 06 Jan 2021 New trial record